Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS Cohort

By sjmartinez • March 13, 2025

Barjaktarevic I, Hixson R, Zhuang Z, Buhr RG, Tejwani V, Barr RG, Bateman LA, Bhatt SP, Bleecker ER, Cooper CB, Curtis JL, Drummond MB, Fortis S, Ghosh AJ, Han M, Hansel NN, Hoffman EA, Ohar J, Martinez FJ, Meyers DA, Paine R 3rd, Pirozzi CS, Sandhaus R, Strange C, Tashkin DP, Wells JM, Woodruff P, Ortega VE. Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS Cohort. Ann Am Thorac Soc. 2025 Mar 11. doi: 10.1513/AnnalsATS.202411-1209OC. Epub ahead of print. PMID: 40068143.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Moderators of the Effects of Telehealth Mindfulness-based Interventions for Chronic Pain: A Secondary Responder Analysis of the LAMP Randomized Controlled Trial

Calvert CM, Hagel Campbell EM, Cross LJS, Bangerter A, Bronfort G, Evans R, Meis LA, Haley A, Leininger B, Matthias M, Polusny M, Allen K,[...]

Leveraging scholarship to lead

Moriates C. Leveraging scholarship to lead. J Hosp Med. 2026 Sep 9. doi: 10.1002/jhm.70478. Epub ahead of print. PMID: 42717657.

Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension

Alotaibi M, Tang A, Sun N, Gurholt I, Yuguchi E, Roberts K, Preston I, Warburton R, Yuan JX, Kim NH, Chan SY, Jain M, Cheng[...]